★ Sign in to follow
JE

Jamal El Mosleh

SE·Finansinspektionen
Elicera Therapeutics AB (publ)Elicera Therapeutics AB
Insider activity · 24 months0 buys4 salesCumulative net flow
Total declarations
18
Companies
2
▲ Purchases (5 ops.)
€317k
▼ Sales (7 ops.)
€531k

Latest filing published 27 May 2025 for Elicera Therapeutics AB (publ), €138k.

Filing timeline

BuySale
Jamal El Mosleh

Insider track record

Disclosed buys
5
Disclosed sells
7
Signal history

Closed purchases

Market purchases
5

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Jamal El Mosleh: trading record in brief

Jamal El Mosleh is a declared insider at 2 companies; the most frequent names are Elicera Therapeutics AB and Elicera Therapeutics AB (publ). Over a trading history stretching from 10 June 2021 to 27 May 2025, the count stands at 18 filings.

The open-market side counts 5 purchases for €317k alongside 7 sales for €531k. The net balance comes to €213k on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 2 share grants. Since January 2025: no purchases and 4 sales on the market.

Half of the purchases are above €4,280 and half below.

The latest filing, published on 27 May 2025, reports an open-market sale of €12k in Elicera Therapeutics AB (publ). The most recent open-market purchase was published on 26 April 2024, 926 days ago. Filings reach the Finansinspektionen feed a median of 1 day after the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.

Companies and markets linked to Jamal El Mosleh

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations17 total
  • ▼
    Jamal El Mosleh
    Verkställande direktör (VD)ExecutivesElicera Therapeutics AB (publ)
    1M SEK27FI-SE
    237,500 shares@ SEK 6.3052.3% of flowAktieISIN SE0015382080FI:csv-c0a27e025ccc391f1cda
  • ▼
    Jamal El Mosleh
    Verkställande direktör (VD)ExecutivesElicera Therapeutics AB (publ)
    667,275 SEK24FI-SE
    102,500 shares@ SEK 6.5123.3% of flowAktieISIN SE0015382080FI:csv-903a21833ecdf42bf033
  • ▼
    Jamal El Mosleh
    Verkställande direktör (VD)ExecutivesElicera Therapeutics AB (publ)
    176,500 SEK23FI-SE
    25,000 shares@ SEK 7.066.2% of flowAktieISIN SE0015382080FI:csv-1ff01fc2b5ef18509685
  • ▼
    Jamal El Mosleh
    Verkställande direktör (VD)ExecutivesElicera Therapeutics AB (publ)
    131,800 SEK22FI-SE
    20,000 shares@ SEK 6.594.6% of flowAktieISIN SE0015382080FI:csv-e852de112021d7095719
  • ●
    Jamal El Mosleh
    Verkställande direktör (VD)ExecutivesElicera Therapeutics AB (publ)
    281,015 SEK23FI-SE
    151,900 shares@ SEK 1.859.7% of flowInterimsaktieISIN SE0015382080FI:csv-87ad5358af11d607291a
  • ▲
    Jamal El Mosleh
    Verkställande direktör (VD)ExecutivesElicera Therapeutics AB
    50,000 SEK22FI-SE
    50,000 shares@ SEK 1.001.2% of flowAktieISIN SE0015382080FI:csv-25b20528b0356f67c84c
    Canonical exit: 24 Jul 2024 (T+90)
  • ▼
    Jamal El Mosleh
    Verkställande direktör (VD)ExecutivesElicera Therapeutics AB
    3M SEK30FI-SE
    2,687,000 shares@ SEK 1.2886.9% of flowAktieISIN SE0015382080FI:csv-e3a9030e63df6127e55f
  • ●
    Jamal El Mosleh
    Verkställande direktör (VD)ExecutivesElicera Therapeutics AB
    351,540 SEK0FI-SE
    21,700 shares@ SEK 16.209.0% of flowBTU (betald tecknad unit)ISIN SE0021626306FI:csv-546cf3d6d9a0d0051b89
  • ▲
    Jamal El Mosleh
    Verkställande direktör (VD)ExecutivesElicera Therapeutics AB
    1,180 SEK0FI-SE
    64,500 shares@ SEK 0.01830.0% of flowTeckningsrätt/UniträttISIN SE0021626298FI:csv-c5f34a26288df3a904dc
    Canonical exit: 26 May 2024 (T+90)
  • ▲
    Jamal El Mosleh
    Verkställande direktör (VD)ExecutivesElicera Therapeutics AB
    158 SEK0FI-SE
    31,000 shares@ SEK 0.00510.0% of flowTeckningsrätt/UniträttISIN SE0021626298FI:csv-5cf1258f715311d396f4
    Canonical exit: 2 Jun 2024 (T+90)
  • ▼
    Jamal El Mosleh
    Verkställande direktör (VD)ExecutivesElicera Therapeutics AB
    1,200 SEK0FI-SE
    500,000 shares@ SEK 0.00240.0% of flowTeckningsrätt/UniträttISIN SE0021626298FI:csv-eee4290288ab2ac113d3
  • ▼
    Jamal El Mosleh
    Verkställande direktör (VD)ExecutivesElicera Therapeutics AB
    2,682 SEK0FI-SE
    1,687,000 shares@ SEK 0.00160.1% of flowTeckningsrätt/UniträttISIN SE0021626298FI:csv-f205cd4a084eaeb106ee
  • ●
    Jamal El Mosleh
    Verkställande direktör (VD)ExecutivesElicera Therapeutics AB
    0FI-SE
    2,583,333 shares0AktieISIN SE0015382080FI:csv-da292808b8c1076455aa
  • ▲
    Jamal El Mosleh
    Verkställande direktör (VD)ExecutivesElicera Therapeutics AB
    98,900 SEK40FI-SE
    23,000 shares@ SEK 4.302.8% of flowAktieISIN SE0015382080FI:csv-9fb67d1526b95ea3a385
    Canonical exit: 3 Oct 2021 (T+90)
  • ●
    Jamal El Mosleh
    Verkställande direktör (VD)ExecutivesElicera Therapeutics AB (publ)
    0FI-SE
    2,583,333 shares0AktieISIN SE0015382080FI:csv-bf38a42509df9f69817b
  • ◆
    Jamal El Mosleh
    Verkställande direktör (VD)ExecutivesElicera Therapeutics AB (publ)
    104,000 SEK30FI-SE
    13,000 shares@ SEK 8.00100.0% of flowAktieISIN SE0015382080FI:csv-fb886e83129e862af7bb
  • ◆
    Jamal El Mosleh
    Verkställande direktör (VD)ExecutivesElicera Therapeutics AB (publ)
    0FI-SE
    13,000 shares0OptionISIN SE0015988233FI:csv-5bf90d6e9d91aad22d16

17 of 17 declarations

Related entities

No related entities found.